StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) stock

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3025% above fair value
$1382.75−32.80 (-2.32%)

Close on Nov 18, 2026Market cap $1.30TP/E 44.9Yield 0.45%

Eli Lilly operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

No operating income figures for Eli Lilly

Eli Lilly has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Eli Lilly figures

See a number that looks wrong?